iShares Biotechnology ETF Rating $126.60 +1.72 (+1.38%) Closing price 04:00 PM EasternExtended Trading$126.96 +0.37 (+0.29%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.69Holdings in IBB have an aggregate rating of Moderate Buy based on 801 analyst ratings issued in the past year covering 50 companies (83.7% of the portfolio).IBB Aggregate Price Target$126.60High Prediction$126.60Average Prediction$126.60Low Prediction$126.60Holdings in IBB have an aggregate price target of $126.60 and a range of $126.60 to $126.60 covering 50 companies (83.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.31%VRTXVertex Pharmaceuticals$501.15+0.5%3.9722 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News8.45%GILDGilead Sciences$103.68+0.4%4.7402 of 5 stars2.78$110.55 6.6%27Dividend Announcement8.19%AMGNAmgen$281.22-0.9%4.5418 of 5 stars2.43$310.22 10.3%23Earnings ReportAnalyst ForecastPositive NewsGap Up7.32%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8421 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading Volume3.54%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.2256 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage3.03%IQVIQVIA$153.42+1.5%4.9602 of 5 stars2.75$237.62 54.9%24Upcoming EarningsGap Up2.96%ARGXargenx$649.67+1.5%2.5306 of 5 stars2.91$699.28 7.6%23Upcoming EarningsPositive NewsGap Up2.54%MTDMettler-Toledo International$1,103.95+4.5%3.7404 of 5 stars2.22$1,304.25 18.1%9Earnings ReportShort Interest ↑Positive NewsHigh Trading Volume2.34%WATWaters$351.16+2.7%4.0157 of 5 stars2.61$392.13 11.7%18Upcoming Earnings2.24%NTRANatera$156.66+3.5%2.894 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider TradePositive News2.21%BNTXBioNTech$104.94+2.5%2.5812 of 5 stars2.89$143.44 36.7%18Upcoming EarningsPositive News2.03%BIIBBiogen$123.53+2.2%4.7154 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastNews Coverage1.62%ONCBeigene$255.77+0.1%1.9825 of 5 stars3.00$318.88 24.7%6Analyst RevisionNews Coverage1.53%UTHRUnited Therapeutics$294.60+0.3%4.9886 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News1.48%INSMInsmed$72.30-0.5%4.3943 of 5 stars3.00$94.00 30.0%16Upcoming EarningsInsider TradeNews CoveragePositive News1.42%ILMNIllumina$77.88+1.8%4.6619 of 5 stars2.48$137.55 76.6%21Upcoming EarningsAnalyst ForecastPositive News1.38%BMRNBioMarin Pharmaceutical$62.03-1.1%4.9303 of 5 stars2.70$92.95 49.9%23Analyst ForecastNews CoveragePositive News1.31%INCYIncyte$62.53+0.8%4.7432 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst Revision1.18%EXELExelixis$39.60+1.8%4.0986 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Analyst RevisionPositive News1.18%NBIXNeurocrine Biosciences$109.68+2.9%4.8854 of 5 stars2.86$160.90 46.7%22Upcoming Earnings1.10%GMABGenmab A/S$21.48+2.6%4.4597 of 5 stars2.69$39.17 82.3%13Upcoming EarningsPositive News1.07%MRNAModerna$27.61+2.1%4.3626 of 5 stars2.04$56.55 104.8%24Earnings ReportAnalyst ForecastNews CoverageGap Up0.93%TECHBio-Techne$50.49+1.7%4.8947 of 5 stars2.38$81.14 60.7%8Upcoming EarningsPositive NewsGap Up0.88%RGENRepligen$141.51+3.1%4.6448 of 5 stars2.64$173.25 22.4%14Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoveragePositive News0.86%MEDPMedpace$305.11+0.9%4.4245 of 5 stars2.23$349.30 14.5%13Short Interest ↑Gap Up0.84%HALOHalozyme Therapeutics$61.19+1.9%4.0233 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst Revision0.78%ASNDAscendis Pharma A/S$172.06+2.7%2.152 of 5 stars2.93$211.40 22.9%15Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume0.71%RVMDRevolution Medicines$40.72+0.2%3.7624 of 5 stars3.00$66.67 63.7%12Upcoming EarningsPositive News0.68%MDGLMadrigal Pharmaceuticals$315.48-3.7%4.6201 of 5 stars2.90$416.33 32.0%10Earnings ReportAnalyst ForecastNews CoveragePositive News0.65%CRLCharles River Laboratories International$118.33+1.2%4.8371 of 5 stars1.94$182.00 53.8%16Upcoming EarningsPositive NewsGap Up0.64%BPMCBlueprint Medicines$104.64+5.4%1.7426 of 5 stars2.68$124.53 19.0%22Earnings ReportAnalyst ForecastNews CoveragePositive News0.63%SRPTSarepta Therapeutics$63.51+1.2%4.7233 of 5 stars2.83$158.70 149.9%240.62%BBIOBridgeBio Pharma$38.57+0.4%4.5837 of 5 stars2.92$57.09 48.0%12Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.58%ADMAADMA Biologics$23.52+1.1%1.4527 of 5 stars3.25$22.50 -4.3%4Upcoming EarningsOptions VolumeNews CoveragePositive NewsGap Up0.56%ROIVRoivant Sciences$11.48-0.9%2.2085 of 5 stars3.00$17.50 52.4%40.53%IONSIonis Pharmaceuticals$32.78+3.4%4.4017 of 5 stars2.65$56.67 72.9%20Earnings ReportAnalyst ForecastInsider TradeNews CoveragePositive News0.52%CYTKCytokinetics$37.35-13.0%4.0817 of 5 stars2.89$76.88 105.8%19Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading Volume0.51%LEGNLegend Biotech$33.17-2.3%2.5246 of 5 stars2.92$78.82 137.6%12Positive News0.51%ALKSAlkermes$31.78+3.9%4.1835 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage0.49%AXSMAxsome Therapeutics$112.210.0%4.8491 of 5 stars3.00$169.87 51.4%16Upcoming EarningsAnalyst ForecastShort Interest ↓News CoveragePositive News0.49%PCVXVaxcyte$35.39+0.4%3.0206 of 5 stars3.10$136.50 285.7%10Upcoming EarningsPositive News0.48%KRYSKrystal Biotech$166.16+0.3%4.9174 of 5 stars3.00$222.71 34.0%8Upcoming EarningsAnalyst RevisionNews CoveragePositive News0.46%TEMTempus AI$57.06+10.0%1.6005 of 5 stars2.54$61.08 7.1%13Upcoming EarningsPositive NewsHigh Trading Volume0.46%BRKRBruker$40.44+2.8%4.9858 of 5 stars2.55$65.00 60.7%11Upcoming EarningsShort Interest ↓Positive NewsHigh Trading Volume0.45%PTCTPTC Therapeutics$49.95+0.9%4.0152 of 5 stars2.53$63.92 28.0%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News0.45%SMMTSummit Therapeutics$27.90+13.1%2.6676 of 5 stars3.00$37.40 34.1%10Earnings ReportAnalyst ForecastAnalyst RevisionGap Up0.40%RYTMRhythm Pharmaceuticals$64.01+0.3%3.7877 of 5 stars3.00$74.92 17.0%13Upcoming EarningsInsider TradePositive News0.40%RNAAvidity Biosciences$32.20-1.5%2.728 of 5 stars3.00$66.69 107.1%13Upcoming EarningsPositive News0.38%RAREUltragenyx Pharmaceutical$39.30+0.8%4.3822 of 5 stars2.93$92.79 136.1%14Upcoming EarningsShort Interest ↑Positive News0.38%NUVLNuvalent$77.46+1.6%1.7238 of 5 stars2.90$115.50 49.1%10Upcoming Earnings This page (NASDAQ:IBB) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBB Stock Free IBB Stock Alerts